Aromatase inhibitor adverse effects: are we sweeping them under the rug?

Affiliations

¹ Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX niravath@bcm.edu.
² Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX.

Comment

Polly Niravath et al. J Clin Oncol. 2014.

. 2014 Nov 20;32(33):3779.

doi: 10.1200/JCO.2014.56.9640. Epub 2014 Aug 25.

¹ Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX niravath@bcm.edu.
² Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX.

No abstract available

Comment on

Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer.
Maunsell E, Goss PE, Chlebowski RT, Ingle JN, Alés-Martínez JE, Sarto GE, Fabian CJ, Pujol P, Ruiz A, Cooke AL, Hendrix S, Thayer DW, Rowland KM, Dubé P, Spadafora S, Pruthi S, Lickley L, Ellard SL, Cheung AM, Wactawski-Wende J, Gelmon KA, Johnston D, Hiltz A, Brundage M, Pater JL, Tu D, Richardson H. Maunsell E, et al. J Clin Oncol. 2014 May 10;32(14):1427-36. doi: 10.1200/JCO.2013.51.2483. Epub 2014 Apr 7. J Clin Oncol. 2014. PMID: 24711552 Free PMC article. Clinical Trial.